Intrinsic Value of S&P & Nasdaq Contact Us

Science 37 Holdings, Inc. SNCE NASDAQ

NASDAQ Global Market • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
36/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Science 37 Holdings, Inc. (SNCE) , forward earnings yield 6.95%. PEG 0.02 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Forward P/E 14.4
  • PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).

Overall SharesGrow Score: 35/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
36/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
29/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SNCE

Valuation Multiples
P/E (TTM)0.0
Forward P/E14.4
PEG Ratio0.02
Forward PEG0.02
P/B Ratio0.00
P/S Ratio9.50
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.44
Forward EPS (Est.)$0.40
Book Value / Share$0.00
Revenue / Share$0.61
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield6.95%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $0.00 $0.00 $-1K -
2020 $-2.18 $23.7M $-32.37M -136.6%
2021 $-2,886.59 $59.6M $-94.33M -158.3%
2022 $-0.44 $70.15M $-50.99M -72.7%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message